{"id":1408,"date":"2016-02-09T15:16:04","date_gmt":"2016-02-09T15:16:04","guid":{"rendered":"https:\/\/www.editage.com\/insights\/amgen-to-publish-negative-results-to-improve-sciences-self-correcting-nature\/"},"modified":"2025-02-25T06:03:27","modified_gmt":"2025-02-25T06:03:27","slug":"amgen-to-publish-negative-results-to-improve-sciences-self-correcting-nature","status":"publish","type":"post","link":"https:\/\/www.editage.com\/insights\/amgen-to-publish-negative-results-to-improve-sciences-self-correcting-nature","title":{"rendered":"Amgen to publish negative results to improve science’s self-correcting nature"},"content":{"rendered":"

Amgen, an American multinational biopharmaceutical company\u00a0headquartered in California, announced in a press release<\/a> on February 4 that it will publish three studies that failed to confirm the findings. These negative results will be published in F1000<\/a>\u2019s newly launched publishing platform called Preclinical Reproducibility and Robustness<\/a><\/em>. In the press release, Sasha Kamb, senior vice president for research discovery at Amgen, states that the main goal behind this decision is to \u201cimprove efficiency and speed in translating basic discoveries into new medicines by decreasing the waste from redundant, non-publicized attempts to build on non-robust findings, and allowing us to focus more on the real breakthroughs.\u201d<\/span><\/p>\n

Since the conventional publishing methods involve huge timelines, Kamb chose F1000Research<\/em>, an open access journal in which studies are checked by editors and then posted online before undergoing peer review. These studies undergo open peer review and then may become eligible to be indexed once if reviewers so suggest. According to Bruce Alberts who is part of\u00a0F1000Research<\/em><\/a>\u2019s advisory board, the intention behind the launch of Preclinical Reproducibility and Robustness<\/em> was encouraging researchers to share negative results, which often go unpublished<\/a>.<\/span><\/p>\n

Amgen has been in the midst of the debate around reproducibility in the past. In 2012, researchers at Amgen had declared that of the 53 groundbreaking papers on cancer, 47 could not be replicated<\/a>. Kamb has clarified that none of those papers are related to the three studies they plan to publish: As mentioned in the Nature\u00a0<\/em>article<\/a>, “<\/span>One study adds to existing criticism of a Science<\/em> paper that suggested that a cancer drug might be a potential treatment for Alzheimer\u2019s disease<\/a>; a second counters earlier findings<\/a>\u00a0(including some by Amgen researchers) connecting a gene to insulin sensitivity in mice<\/a>; and a third counters a Nature<\/em> paper<\/a> reporting that inhibiting one particular protein could enhance degradation of other proteins associated with neurodegenerative diseases.” Kamb<\/span>\u00a0hopes that other companies would follow Amgen\u2019s footsteps in publishing negative findings and helping in hastening scientific progress.<\/span><\/p>\n

While several researchers are supportive of this initiative, some have expressed reservations. John Ioannidis at Stanford University, who studies reproducibility of research, points out that the scientific community is not yet open about publishing negative results and replication studies. Therefore, how successful Amgen\u2019s initiative becomes remains to be seen. \u00a0\u00a0<\/span><\/p>\n

References<\/em><\/strong><\/span><\/p>\n

If you fail to reproduce another scientist\u2019s results, this journal wants to know<\/em><\/a> (accessed February 5)<\/em><\/span><\/p>\n

Biotech giant publishes failures to confirm high-profile science<\/em><\/a> (accessed February 5)<\/em><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

Amgen, an American multinational biopharmaceutical company\u00a0headquartered in California, announced in a press release on February 4 that it will publish three studies that failed to confirm the findings. These negative results will be published in F1000\u2019s newly launched publishing platform called Preclinical Reproducibility and Robustness. In the press release, Sasha Kamb, senior vice president for […]<\/p>\n","protected":false},"author":4,"featured_media":33313,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[2408],"tags":[498,628,39],"new_categories":[],"new_tags":[],"series":[],"class_list":["post-1408","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-industry-news","tag-global-trends","tag-negative-results","tag-publication-bias"],"acf":[],"yoast_head":"\nAmgen to publish negative results to improve science's self-correcting nature | Editage Insights<\/title>\n<meta name=\"description\" content=\"Amgen, an American multinational biopharmaceutical company headquartered in California, announced in a press release that it will publish three studies that failed to confirm the findings in a new F1000Research journal.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.editage.com\/insights\/amgen-to-publish-negative-results-to-improve-sciences-self-correcting-nature\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Amgen to publish negative results to improve science's self-correcting nature | Editage Insights\" \/>\n<meta property=\"og:description\" content=\"Amgen, an American multinational biopharmaceutical company headquartered in California, announced in a press release that it will publish three studies that failed to confirm the findings in a new F1000Research journal.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.editage.com\/insights\/amgen-to-publish-negative-results-to-improve-sciences-self-correcting-nature\" \/>\n<meta property=\"og:site_name\" content=\"Editage Insights\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Editage\" \/>\n<meta property=\"article:published_time\" content=\"2016-02-09T15:16:04+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-25T06:03:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.editage.com\/insights\/wp-content\/uploads\/2018\/09\/Amgen-to-publish-negative-results-to-improve-sciences-self-correcting-nature_0.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"656\" \/>\n\t<meta property=\"og:image:height\" content=\"438\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Sneha Kulkarni\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@Editage\" \/>\n<meta name=\"twitter:site\" content=\"@Editage\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sneha Kulkarni\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.editage.com\/insights\/amgen-to-publish-negative-results-to-improve-sciences-self-correcting-nature#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.editage.com\/insights\/amgen-to-publish-negative-results-to-improve-sciences-self-correcting-nature\"},\"author\":{\"name\":\"Sneha Kulkarni\",\"@id\":\"https:\/\/www.editage.com\/insights\/#\/schema\/person\/7c95168c8a381719f987ecc0eb49d20d\"},\"headline\":\"Amgen to publish negative results to improve science’s self-correcting nature\",\"datePublished\":\"2016-02-09T15:16:04+00:00\",\"dateModified\":\"2025-02-25T06:03:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.editage.com\/insights\/amgen-to-publish-negative-results-to-improve-sciences-self-correcting-nature\"},\"wordCount\":417,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.editage.com\/insights\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.editage.com\/insights\/amgen-to-publish-negative-results-to-improve-sciences-self-correcting-nature#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.editage.com\/insights\/wp-content\/uploads\/2025\/02\/editage-insights-generic-banner_298.webp\",\"keywords\":[\"global trends\",\"negative results\",\"publication bias\"],\"articleSection\":[\"Industry News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.editage.com\/insights\/amgen-to-publish-negative-results-to-improve-sciences-self-correcting-nature#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.editage.com\/insights\/amgen-to-publish-negative-results-to-improve-sciences-self-correcting-nature\",\"url\":\"https:\/\/www.editage.com\/insights\/amgen-to-publish-negative-results-to-improve-sciences-self-correcting-nature\",\"name\":\"Amgen to publish negative results to improve science's self-correcting nature | Editage Insights\",\"isPartOf\":{\"@id\":\"https:\/\/www.editage.com\/insights\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.editage.com\/insights\/amgen-to-publish-negative-results-to-improve-sciences-self-correcting-nature#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.editage.com\/insights\/amgen-to-publish-negative-results-to-improve-sciences-self-correcting-nature#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.editage.com\/insights\/wp-content\/uploads\/2025\/02\/editage-insights-generic-banner_298.webp\",\"datePublished\":\"2016-02-09T15:16:04+00:00\",\"dateModified\":\"2025-02-25T06:03:27+00:00\",\"description\":\"Amgen, an American multinational biopharmaceutical company headquartered in California, announced in a press release that it will publish three studies that failed to confirm the findings in a new F1000Research journal.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.editage.com\/insights\/amgen-to-publish-negative-results-to-improve-sciences-self-correcting-nature#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.editage.com\/insights\/amgen-to-publish-negative-results-to-improve-sciences-self-correcting-nature\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.editage.com\/insights\/amgen-to-publish-negative-results-to-improve-sciences-self-correcting-nature#primaryimage\",\"url\":\"https:\/\/www.editage.com\/insights\/wp-content\/uploads\/2025\/02\/editage-insights-generic-banner_298.webp\",\"contentUrl\":\"https:\/\/www.editage.com\/insights\/wp-content\/uploads\/2025\/02\/editage-insights-generic-banner_298.webp\",\"width\":656,\"height\":336},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.editage.com\/insights\/amgen-to-publish-negative-results-to-improve-sciences-self-correcting-nature#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.editage.com\/insights\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Amgen to publish negative results to improve science’s self-correcting nature\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.editage.com\/insights\/#website\",\"url\":\"https:\/\/www.editage.com\/insights\/\",\"name\":\"Editage Insights\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.editage.com\/insights\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.editage.com\/insights\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.editage.com\/insights\/#organization\",\"name\":\"Editage Insights\",\"url\":\"https:\/\/www.editage.com\/insights\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.editage.com\/insights\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.editage.com\/insights\/wp-content\/uploads\/2024\/09\/editage-insights-logo-1-scaled.webp\",\"contentUrl\":\"https:\/\/www.editage.com\/insights\/wp-content\/uploads\/2024\/09\/editage-insights-logo-1-scaled.webp\",\"width\":2560,\"height\":324,\"caption\":\"Editage Insights\"},\"image\":{\"@id\":\"https:\/\/www.editage.com\/insights\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/Editage\",\"https:\/\/x.com\/Editage\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.editage.com\/insights\/#\/schema\/person\/7c95168c8a381719f987ecc0eb49d20d\",\"name\":\"Sneha Kulkarni\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.editage.com\/insights\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bb54352821d99f6174b14235a21b38dafe7a9649e6f269e8abd97284e09ad189?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bb54352821d99f6174b14235a21b38dafe7a9649e6f269e8abd97284e09ad189?s=96&d=mm&r=g\",\"caption\":\"Sneha Kulkarni\"},\"url\":\"https:\/\/www.editage.com\/insights\/sneha-kulkarni\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Amgen to publish negative results to improve science's self-correcting nature | Editage Insights","description":"Amgen, an American multinational biopharmaceutical company headquartered in California, announced in a press release that it will publish three studies that failed to confirm the findings in a new F1000Research journal.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.editage.com\/insights\/amgen-to-publish-negative-results-to-improve-sciences-self-correcting-nature","og_locale":"en_US","og_type":"article","og_title":"Amgen to publish negative results to improve science's self-correcting nature | Editage Insights","og_description":"Amgen, an American multinational biopharmaceutical company headquartered in California, announced in a press release that it will publish three studies that failed to confirm the findings in a new F1000Research journal.","og_url":"https:\/\/www.editage.com\/insights\/amgen-to-publish-negative-results-to-improve-sciences-self-correcting-nature","og_site_name":"Editage Insights","article_publisher":"https:\/\/www.facebook.com\/Editage","article_published_time":"2016-02-09T15:16:04+00:00","article_modified_time":"2025-02-25T06:03:27+00:00","og_image":[{"width":656,"height":438,"url":"https:\/\/www.editage.com\/insights\/wp-content\/uploads\/2018\/09\/Amgen-to-publish-negative-results-to-improve-sciences-self-correcting-nature_0.jpg","type":"image\/jpeg"}],"author":"Sneha Kulkarni","twitter_card":"summary_large_image","twitter_creator":"@Editage","twitter_site":"@Editage","twitter_misc":{"Written by":"Sneha Kulkarni","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.editage.com\/insights\/amgen-to-publish-negative-results-to-improve-sciences-self-correcting-nature#article","isPartOf":{"@id":"https:\/\/www.editage.com\/insights\/amgen-to-publish-negative-results-to-improve-sciences-self-correcting-nature"},"author":{"name":"Sneha Kulkarni","@id":"https:\/\/www.editage.com\/insights\/#\/schema\/person\/7c95168c8a381719f987ecc0eb49d20d"},"headline":"Amgen to publish negative results to improve science’s self-correcting nature","datePublished":"2016-02-09T15:16:04+00:00","dateModified":"2025-02-25T06:03:27+00:00","mainEntityOfPage":{"@id":"https:\/\/www.editage.com\/insights\/amgen-to-publish-negative-results-to-improve-sciences-self-correcting-nature"},"wordCount":417,"commentCount":0,"publisher":{"@id":"https:\/\/www.editage.com\/insights\/#organization"},"image":{"@id":"https:\/\/www.editage.com\/insights\/amgen-to-publish-negative-results-to-improve-sciences-self-correcting-nature#primaryimage"},"thumbnailUrl":"https:\/\/www.editage.com\/insights\/wp-content\/uploads\/2025\/02\/editage-insights-generic-banner_298.webp","keywords":["global trends","negative results","publication bias"],"articleSection":["Industry News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.editage.com\/insights\/amgen-to-publish-negative-results-to-improve-sciences-self-correcting-nature#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.editage.com\/insights\/amgen-to-publish-negative-results-to-improve-sciences-self-correcting-nature","url":"https:\/\/www.editage.com\/insights\/amgen-to-publish-negative-results-to-improve-sciences-self-correcting-nature","name":"Amgen to publish negative results to improve science's self-correcting nature | Editage Insights","isPartOf":{"@id":"https:\/\/www.editage.com\/insights\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.editage.com\/insights\/amgen-to-publish-negative-results-to-improve-sciences-self-correcting-nature#primaryimage"},"image":{"@id":"https:\/\/www.editage.com\/insights\/amgen-to-publish-negative-results-to-improve-sciences-self-correcting-nature#primaryimage"},"thumbnailUrl":"https:\/\/www.editage.com\/insights\/wp-content\/uploads\/2025\/02\/editage-insights-generic-banner_298.webp","datePublished":"2016-02-09T15:16:04+00:00","dateModified":"2025-02-25T06:03:27+00:00","description":"Amgen, an American multinational biopharmaceutical company headquartered in California, announced in a press release that it will publish three studies that failed to confirm the findings in a new F1000Research journal.","breadcrumb":{"@id":"https:\/\/www.editage.com\/insights\/amgen-to-publish-negative-results-to-improve-sciences-self-correcting-nature#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.editage.com\/insights\/amgen-to-publish-negative-results-to-improve-sciences-self-correcting-nature"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.editage.com\/insights\/amgen-to-publish-negative-results-to-improve-sciences-self-correcting-nature#primaryimage","url":"https:\/\/www.editage.com\/insights\/wp-content\/uploads\/2025\/02\/editage-insights-generic-banner_298.webp","contentUrl":"https:\/\/www.editage.com\/insights\/wp-content\/uploads\/2025\/02\/editage-insights-generic-banner_298.webp","width":656,"height":336},{"@type":"BreadcrumbList","@id":"https:\/\/www.editage.com\/insights\/amgen-to-publish-negative-results-to-improve-sciences-self-correcting-nature#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.editage.com\/insights\/"},{"@type":"ListItem","position":2,"name":"Amgen to publish negative results to improve science’s self-correcting nature"}]},{"@type":"WebSite","@id":"https:\/\/www.editage.com\/insights\/#website","url":"https:\/\/www.editage.com\/insights\/","name":"Editage Insights","description":"","publisher":{"@id":"https:\/\/www.editage.com\/insights\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.editage.com\/insights\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.editage.com\/insights\/#organization","name":"Editage Insights","url":"https:\/\/www.editage.com\/insights\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.editage.com\/insights\/#\/schema\/logo\/image\/","url":"https:\/\/www.editage.com\/insights\/wp-content\/uploads\/2024\/09\/editage-insights-logo-1-scaled.webp","contentUrl":"https:\/\/www.editage.com\/insights\/wp-content\/uploads\/2024\/09\/editage-insights-logo-1-scaled.webp","width":2560,"height":324,"caption":"Editage Insights"},"image":{"@id":"https:\/\/www.editage.com\/insights\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Editage","https:\/\/x.com\/Editage"]},{"@type":"Person","@id":"https:\/\/www.editage.com\/insights\/#\/schema\/person\/7c95168c8a381719f987ecc0eb49d20d","name":"Sneha Kulkarni","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.editage.com\/insights\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bb54352821d99f6174b14235a21b38dafe7a9649e6f269e8abd97284e09ad189?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bb54352821d99f6174b14235a21b38dafe7a9649e6f269e8abd97284e09ad189?s=96&d=mm&r=g","caption":"Sneha Kulkarni"},"url":"https:\/\/www.editage.com\/insights\/sneha-kulkarni"}]}},"_links":{"self":[{"href":"https:\/\/www.editage.com\/insights\/wp-json\/wp\/v2\/posts\/1408","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.editage.com\/insights\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.editage.com\/insights\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.editage.com\/insights\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.editage.com\/insights\/wp-json\/wp\/v2\/comments?post=1408"}],"version-history":[{"count":0,"href":"https:\/\/www.editage.com\/insights\/wp-json\/wp\/v2\/posts\/1408\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.editage.com\/insights\/wp-json\/wp\/v2\/media\/33313"}],"wp:attachment":[{"href":"https:\/\/www.editage.com\/insights\/wp-json\/wp\/v2\/media?parent=1408"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.editage.com\/insights\/wp-json\/wp\/v2\/categories?post=1408"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.editage.com\/insights\/wp-json\/wp\/v2\/tags?post=1408"},{"taxonomy":"new_categories","embeddable":true,"href":"https:\/\/www.editage.com\/insights\/wp-json\/wp\/v2\/new_categories?post=1408"},{"taxonomy":"new_tags","embeddable":true,"href":"https:\/\/www.editage.com\/insights\/wp-json\/wp\/v2\/new_tags?post=1408"},{"taxonomy":"series","embeddable":true,"href":"https:\/\/www.editage.com\/insights\/wp-json\/wp\/v2\/series?post=1408"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}